Search Results 641-650 of 11523 for VEO-IBD

  1. Multi-Center Prospective Validation Study of VTE Risk Prediction Tool in Trauma Patients - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from injury ...

  2. A Study of Early-onset Alzheimer's Disease - Mayo Clinic

    Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

  3. VE303 for Prevention of Recurrent Clostridioides Difficile Infection - Mayo Clinic

    -History of confirmed celiac disease, inflammatory bowel disease, microscopic colitis, short gut, GI tract fistulas, or a recent episode (within 6 months of ...

  4. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

    ... inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson ...

  5. A Study to Evaluate the Pharmacokinetics of Low-Dose Bevacuzimab in Reducing Free Plasma VEGF-A in Hemodialysis Patients - Mayo Clinic

    The purpose of this study is to see how hemodialysis patients respond to a very low dose of Avastin (bevacizumab) by measuring the concentration of the ...

  6. A Study to Evaluate the Safety and Effectiveness of Idecabtagene Vicleucel to Treat Multiple Myeloma - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of nonconforming idecabtagene vicleucel (ide-cel) in subjects with multiple myeloma per ...

  7. Submandibular Gland Needle Core Biopsy and Skin Punch Biopsy as Tissue Biomarkers for the Diagnosis and Monitoring of Disease Progression of Parkinson’s Disease and REM Sleep Behavior Disorder - Mayo Clinic

    About this study. Determine 1) the magnitude of SMG and skin a-syn density change over time, 2) the. improvement in adequate tissue acquisition doing ...

  8. Contact - Early-Onset Parkinson's Disease and Synucleinopathies - Mayo Clinic Research

    Rodolfo Savica, M.D., Ph.D. Early-Onset Parkinson's Disease and Synucleinopathies Laboratory; Mayo Clinic Gonda Building, Eighth Floor 200 First Street SW

  9. Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme - Mayo Clinic

    About this study. This partially randomized phase I/II trial studies the side effects and the best dose of anti-endoglin monoclonal antibody TRC105 when ...

  10. A Study of Healthy Donor Volunteers to Provide Blood components Via Leukapheresis for In vitro Dendritic Cell Investigations - Mayo Clinic

    The purpose of this study is to collect blood cells as a healthy donor for use in research studies, which will focus especially on using the immune system's ...